|Videos|August 30, 2021
Deep Dive: Deep Dive Into the RPH-104 Molecule
Yan Lavrovsky, MD, PhD discusses the RPH-104 Molecule, a biological project that is currently being developed to treat a variety of inflammatory diseases, metabolic diseases, recurrent fever, joint lesions, and rashes. Dr. Lavrovsky discusses why the FDA approval of the molecule is so groundbreaking, future research, and what first sparked his team’s interest in researching and developing the RPH-104 molecule.
Related Articles
- Deep Dive: Into Volunteer Veterinarians and Amici Cannis
August 18th 2023
- After Hours: Ballroom Dancing
August 14th 2023
- After Hours: MayhemTom
August 2nd 2023
- Deep Dive: Into Addressing ADHD With Dietary Improvements
July 31st 2023
- Deep Dive: Into Health Care and the Environment
July 26th 2023
- Behind the Science: Behind Antimicrobial Resistance
July 18th 2023